Category: Alzheimer's Disease
Europe Alzheimer's Disease
-
Europe Alzheimer’s Disease Therapeutics & Diagnostics Market Forecast 2024-2032
... at $2105.39 million in 2023 and is expected to reach a revenue of $3594.76 million by 2032. MARKET INSIGHTS The Europe Alzheimer's disease therapeutics & diagnostics market is experiencing substantial growth due to the rising ... Read More
-
Citicoline Market Research Report Information by Product (Capsules, Tablets, Powder, Eye Drops, and Injection) by Application (Sports Nutrition, Personal Wellness, Treatment [Glaucoma, Stroke, Alzheimer disease, Channel (pression, and Others]), by Age Group (Pediatric, Adult, and Geriatric) by Distribution Channel (Online Channel, Offline Channel), by Region (North America, Europe, Asia-Pacific, and Rest of the World) Industry Forecast till 2032
... Geriatric) by Distribution Channel (Online Channel, Offline Channel), by Region (North America, Europe, Asia-Pacific, and Rest of the World) Industry Forecast till 2032 The Citicoline market was valued at USD 0.43 billion in 2023 and ... Read More
-
Mild Cognitive Impairment Market Research Report By Disease Type (Amnestic MCI and Non-Amnestic MCI), By Age (Child, Adult, Geriatric), By Indication (Lewy Body Dementia, Parkinson’s Disease Dementia, Alzheimer’s Disease, Vascular Dementia, and Others) By Treatment (Medication (Cholinesterase Inhibitors, Benzodiazepines, Glutamate Inhibitors, Antihistamines, Mao Inhibitors, Proton Pump Inhibitors, and Others), Therapy (Cognitive Stimulation Therapy, Cognitive Behavioural Therapy (CBT)), And By Region (North America, Europe, Asia-Pacific, And Rest Of The World – Industry Forecast Till 2032
... (Medication (Cholinesterase Inhibitors, Benzodiazepines, Glutamate Inhibitors, Antihistamines, Mao Inhibitors, Proton Pump Inhibitors, and Others), Therapy (Cognitive Stimulation Therapy, Cognitive Behavioural Therapy (CBT)), And By Region (North America, Europe, Asia-Pacific, And Rest Of The World – ... Read More
-
Dementia Drugs Market: Global Market Size, Forecast, Insights, Segmentation, and Competitive Landscape with Impact of COVID-19 & Russia-Ukraine War
... 2025-2034. This report on global dementia drugs market report provides holistic understanding of the market along with market sizing, forecast, drivers, challenges, and competitive landscape. The report presents a clear picture of the global dementia ... Read More
-
Global Blarcamesine Market, By Route of Adminsitration (Oral, Parenteral), By Application (Alzheimer's Disease, Parkinson's Disease , Dementia, Rett Syndrome, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East and Africa).
... Pacific, Latin America, Middle East and Africa). Global blarcamesin market will be valued at US$ 822.2 Mn in 2026 and is expected to reach US$ 992.4 Mn by 2031, exhibiting a compound annual growth rate ... Read More
-
Neuroregeneration Therapy Market, By Type of Neuroregeneration Therapy (Stem Cell Therapy, Gene Therapy, Pharmacological Therapy, Neurostimulation Therapy, Others), By Indication (Spinal Cord Injury, Stroke, Traumatic Brain Injury, Parkinson\'s Disease, Alzheimer\'s Disease, Multiple Sclerosis, Peripheral Nerve Injury, Others), By Mode of Administration (Oral, Injectable, Implantable, Others), By Age Group (Pediatric, Adult, Geriatric), By End User (Hospitals, Specialty Clinics, Research Institutes, Rehabilitation Centers, Others), By Geography (North America, Latin America, Europe, Middle East & Africa, and Asia Pacific)
... Injury, Others), By Mode of Administration (Oral, Injectable, Implantable, Others), By Age Group (Pediatric, Adult, Geriatric), By End User (Hospitals, Specialty Clinics, Research Institutes, Rehabilitation Centers, Others), By Geography (North America, Latin America, Europe, Middle ... Read More
-
Europe Enteral and Parenteral Medical Nutrition Market Forecast to 2028 - Regional Analysis By Indication [Elderly, Gastrointestinal Disorders (IBD, IBS, and Others), Diabetes, Cancer, Respiratory Disorders, Alzheimer’s Disease, Dementia, Renal Disease, Liver Failure, Post COVID-19, and Other Indications], Nutrition Type (Supplemental and Sole Source), Form (Liquid, Powder, and Semi Solid), Product Type (General and Disease Specific), Route of Administration (Oral, Tube Feed, and Parenteral), Age Group (Above 60 Years, 18-60 Years, 3-18 Years, and Below 3 Years), and Distribution Channel (Hospital Pharmacies, Retail Stores, E-Commerce, and Others)
... and Other Indications], Nutrition Type (Supplemental and Sole Source), Form (Liquid, Powder, and Semi Solid), Product Type (General and Disease Specific), Route of Administration (Oral, Tube Feed, and Parenteral), Age Group (Above 60 Years, 18-60 ... Read More
-
Alzheimer’s Disease Market: Distribution by Type of Treatment (Symptomatic and Disease Modifying), Symptomatic Indications (Dementia, Insomnia and Other Psychological Symptoms) and Geography (North America, Europe and Asia-Pacific), 2021-2030
... characterized by the death of brain cells, eventually leading to memory loss, cognitive dysfunction and dementia. Accounting for 60-70% cases of dementia, Alzheimer’s disease is known to be the sixth leading cause of death in ... Read More
-
Europe Medical Marijuana Market Forecast to 2028 – Regional Analysis – by Product Type (Dried Form and Extract Form), Application (Pain Management, Tourette’s, Alzheimer’s Disease, Migraines, Depression and Anxiety, Multiple Sclerosis, Cancer, and Others), and Distribution Channel (Retail Pharmacy, E-Commerce, and Others)
... Distribution Channel (Retail Pharmacy, E-Commerce, and Others) The Europe medical marijuana market is expected to grow from US$ 3,414.26 million in 2022 to US$ 9,703.38 million by 2028. It is estimated to register a CAGR ... Read More
-
Neurodegenerative Disease Market, By Indication Type (Parkinson's Disease, Alzheimer's Disease, Multiple Sclerosis, Huntington Disease, and Other Indication Types), By Drug Type (N-methyl-D-aspartate Receptor antagonists, Cholinesterase Inhibitors, Dopamine Agonists, Immunomodulatory Drugs, and Other Drug Types), and By Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030
... By Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030 Neurodegenerative disease is a type of disease in which cells of the central ... Read More
-
Vocal Biomarkers Market - Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2019–2029, Segmented By Type (Frequency, Amplitude, Error Rate, Vocal Rise/Fall Time, Phonation Time, Voice Tremor, Pitch); By Indications (Depression, Attention Deficit, Disruptive Behavior Disorders); By Neurological Disorders (Parkinson's Disease, Alzheimer's Disease, Huntington's Disease, Respiratory & Cardiovascular Disorders, Traumatic Brain Injury); By End User (Hospitals & Clinics, Academic & Research); By Region (North America, Europe, Asia Pacific, Middle East & Africa, Latin America)
... Behavior Disorders); By Neurological Disorders (Parkinson's Disease, Alzheimer's Disease, Huntington's Disease, Respiratory & Cardiovascular Disorders, Traumatic Brain Injury); By End User (Hospitals & Clinics, Academic & Research); By Region (North America, Europe, Asia Pacific, Middle ... Read More
-
Alzheimer’s disease diagnostics and therapeutics Market, by Product (Therapeutics (Cholinesterase Inhibitors, NMDA Receptor Antagonists, Others) and Diagnostics (Brain Imaging, CSF Test for Alzheimer’s Disease)), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030 Alzheimer’s disease is a neurodegenerative disease that usually starts slowly and progressively worsens. It is a progressive form of dementia, a continuous decline ... Read More
-
Alzheimer's Disease Diagnostics and Therapeutics Market, By Product (Therapeutics [Cholinesterase Inhibitors, NMDA Receptor Antagonists, and Other Therapeutics] and Diagnostics [Brain Imaging and CSF Test for Alzheimer’s Disease]) and By Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028
... East and Africa, and South America) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028 Alzheimer's disease is a neurodegenerative disease that usually starts slowly and progressively worsens. It is a progressive form of ... Read More
-
Europe Alzheimer’s Disease Therapeutics And Diagnostics Market 2022-2028
... duration of 2022-2028. Germany, Spain, the United Kingdom, Italy, France, and Rest of Europe are included in the market in this region. A network of “memory centers,” which specialize in neurodegenerative disease diagnosis, has been ... Read More
Research Assistance
